Use of complementary and alternative medicines by children and adolescents with inflammatory bowel disease
- 26 November 2004
- journal article
- Published by Wiley in Journal of Paediatrics and Child Health
- Vol. 40 (12) , 681-684
- https://doi.org/10.1111/j.1440-1754.2004.00510.x
Abstract
The use of complementary and alternative medicines (CAM) appears increasingly prevalent in children and adolescents. Individuals with chronic illness may have patterns of greater usage. This questionnaire-based study aimed to ascertain the frequency of use by a group of children with proven inflammatory bowel disease (IBD) and to consider the reasons for their use. A questionnaire was sent by mail to the parents of patients currently attending a paediatric IBD clinic. Parents were asked to describe their child's usage of alternative and probiotic therapies and to comment on a number of aspects of such therapies. Forty-six (77%) of 60 mailed questionnaires were returned. The mean age of the children was 10.9 (+/- 4.1) years and they were taking an average of 1.7 (+/- 0.8) prescribed medications. Thirty-three (72%) of the children were said by their parents to be having CAM, with four having five or more such therapies (average 2.4 +/- 1.3 agents per child). The most commonly used agents were probiotics (78%) and fish oils (56%). A minority (12%) of respondents reported that their child's CAM was very effective, although many (50%) noted partial benefits. The 13 children who had never used any CAM therapies ('non-users') did not differ from the 'users' in terms of gender, age, disease or duration of disease. As expected, non-users expressed greater concerns about use of CAM and described different attitudes towards such therapies. Complementary and alternative medicines, especially probiotic therapies, frequently are administered to children and adolescents with inflammatory bowel disease. Often this appears to be due to parental frustration with managing their child's chronic illness. Practitioners caring for children and adolescents with IBD need to be aware that their patients may be using alternative therapies and adopt an open attitude in this situation.Keywords
This publication has 20 references indexed in Scilit:
- Probiotics in inflammatory bowel disease—therapeutic rationale and roleAdvanced Drug Delivery Reviews, 2004
- Use of complementary and alternative medicine in children: Too important to ignoreJournal of Paediatrics and Child Health, 2003
- Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trialGastroenterology, 2003
- n-3 Fatty acids for the treatment of inflammatory bowel diseasesProceedings of the Nutrition Society, 2002
- Complementary medicine use in children and young adults with inflammatory bowel diseaseAmerican Journal of Gastroenterology, 2002
- A pilot study of N‐acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2000
- Use of complementary treatment by those hospitalised with acute illnessArchives of Disease in Childhood, 1999
- The role of complementary medicine in European and Asian patients with inflammatory bowel diseasePublic Health, 1998
- Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's DiseaseNew England Journal of Medicine, 1996
- Prevalence and cost of alternative medicine in AustraliaThe Lancet, 1996